EZH2: a novel target for cancer treatment.
J Hematol Oncol. 2020 Jul 28;13(1):104. doi: 10.1186/s13045-020-00937-8.
J Hematol Oncol. 2020.
PMID: 32723346
Free PMC article.
Review.